AIDS and intestinal disease

Current Opinion in Gastroenterology

Volumn 13, Issue 1, 1997, Pages 18-23

  McGowan, Ian ^a   Anton, Peter ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DIARRHEA; DISEASE COURSE; GASTROINTESTINAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INTESTINE MUCOSA; LYMPHOID TISSUE; MALABSORPTION; NUTRITIONAL SUPPORT; OPPORTUNISTIC INFECTION; PATHOGENESIS; REVIEW; T LYMPHOCYTE; WEIGHT REDUCTION;

EID: 0030893891     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199701000-00004     Document Type: Review

References (66)

1. Centers for Disease Control: First 500,00 AIDS cases: United States, 1995. MMWR Morbid Mortal Wkly Rep 1995, 44:849-853.
2. Rosenberg PS: Scope of the AIDS epidemic in the United States. Science 1995, 270:1372-1375.
3. May GR, Gill MJ, Church DL, Sutherland LR: Gastrointestinal symptoms in ambulatory HIV-infected patients. Dig Dis Sci 1993, 38:1388-1394.
4. Sharpstone D, Gazzard B: Gastrointestinal manifestations of HIV infection. Lancet 1996, 348:379-383.
5. Kotler DP, Reka S, Bereich A, Cronin WJ: Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV. Am J Pathol 1991, 139:823-830.
6. Ehrenpreis ED, Patterson BK, Brainer JA, Yokoo H, Rademaker AW, Glogowski W, Noskin GA, Craig RM: Histopathologic findings of duodenal biopsy specimens in HIV-infected patients with and without diarrhea and malabsorption. Am J Clin Pathol 1992, 97:21-28.
7. Ullrich R, Zeitz M, Heise W, L'age M, Hoffken G, Riecken EO: Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med 1989, 111:15-21.
8. Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W, Levy JA: Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988, i:259-262.
9. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez-Scarano F: Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A 1993, 90:2700-2704.
10. Yahi N, Baghdiguian S, Moreau H, Fantini J: Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J Virol 1992, 66:4848-4854.
11. Amerongen HM, Weltzin R, Mack JA, Winner LS, Michetti P, Apter FM, Kraehenbuhl JP, Neutra MR: M cell-mediated antigen transport and monoclonal IgA antibodies for mucosal immune protection. Ann N Y Acad Sci 1992, 664:18-26.
12. Amerongen HM, Weltzin R, Farnet CM, Michetti P, Haseltine WA, Neutra MR: Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1991, 4:760-765.
13. Hussain LA, Kelly CG, Fellowes R, Hecht EM, Wilson J, Chapman M, Lehner T: Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium. Clin Exp Immunol 1992, 90:530-538.
14. Curtis BM, Scharnowske S, Watson AJ: Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci U S A 1992, 89:8356-8360.
15. Phillips DM, Bourinbaiar AS: Mechanism of HIV spread from lymphocytes to epithelia. Virology 1992, 186:261-273.
16. Bourinbaiar AS, Phillips DM: Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr Hum Retrovirol 1991, 4:56-63.
17. McGowan I, Tenant-Flowers M, Jewell DP: Identification of HIV-1 viral RNA in intestinal tissue from patients with early and late HIV infection. AIDS 1996, 10:458-459. A nested polymerase chain reaction assay was able to detect HIV-1 RNA in small and large intestinal tissue biopsies from HIV-infected patients with early and late disease, indicating that mucosal HIV-1 viral replication may occur throughout the natural history of HIV infection.
18. Jarry A, Cortez A, Rene E, Muzeau F, Brousse N: Infected cells and immune cells in the gastrointestinal tract of AIDS patients: an immunohistochemical study of 127 cases. Histopathology 1990, 16:133-140.
19. Lim SG, Condez A, Lee CA, Johnson MA, Elia C, Poulter LW: Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993, 92:448-454.
20. + lymphocytes as compared with the peripheral blood in the patients with HIV infection. The authors speculated that profound mucosal immunodeficiency may occur, whereas circulating T-cell populations are preserved.
21. Kotler DP, Scholes JV, Tierney AR: Intestinal plasma cell alterations in acquired immunodeficiency syndrome. Dig Dis Sci 1987, 32:129-138.
22. Benhamou Y, Kapel N, Hoang C, Matta H, Meillet D, Magne D, Raphael M, Gentilini M, Opolon P, Gobert JG: Inefficacy of intestinal secretory immune response to Cryptosporidium in acquired immunodeficiency syndrome. Gastroenterology 1995, 108:627-635. Intestinal immunoglobulin secretion was studied in patients with AIDS-related enteric infection, patients with AIDS without enteric infection, and control patients. Intestinal IgA and IgM plasma cells were quantitated using digital image analysis and total IgA as well as anticryptosporidium IgA, IgM, and IgG measured in serum and feces. Contrary to previous reports, mucosal IgA plasma cells, fecal IgA, and serum IgA were normal or increased in patients with AIDS as compared with control patients. It appears that local defects in cell-mediated rather than humoral immunity may predispose to HIV-associated eneteric infection.
23. Snijdeis F, van Deventer SJ, Bartelsman JF, den Otter P, Jansen J, Mevissen ML, van Gool T, Danner SA, Reiss P: Diarrhoea in HIV-infected patients: no evidence of cytokine-mediated inflammation in jejunal mucosa. AIDS 1995, 9:367-373.
24. Sharpstone DR, Rowbottom AW, Nelson MR, Lepper MW, Gazzard BG: Faecal tumour necrosis factor-α in individuals with HIV-related diarrhoea. AIDS 1996, 10:989-994.
25. Johanson JF, Sonnenberg A: Efficient management of diarrhea in the acquired immunodeficiency syndrome (AIDS): a medical decision analysis. Ann Intern Med 1990, 112:942-948.
26. Rabeneck L: Diagnostic workup strategies for patients with HIV-related chronic diarrhea: what is the end result? J Clin Gastroenterol 1993, 16:245-250.
27. Wilcox CM, Schwartz DA, Cotsonis G, Thompson SE: Chronic unexplained diarrhea in human immunodeficiency virus infection: determination of the best diagnostic approach. Gastroenterology 1996, 110:30-37 The optimal investigation of diarrhea in HIV infection remains controversial. In a comprehensive evaluation of 48 patients, these authors demonstrated that the absence of weight loss and CD4 counts greater than 100/μm defined a population in whom agressive investigation was unlikely to yield specific diagnoses.
28. Crotty B, Smallwood RA: Investigating diarrhea in patients with acquired immunodeficiency syndrome. Gastroenterology 1996, 110:296-310.
29. Simon D, Kotler DP, Brandt LJ: Chronic unexplained diarrhea in human immunodeficiency infection: determination of the best diagnostic approach. Gastroenterology 1996, 111:269-270.
30. Connolly GM, Forbes A, Gazzard BG: Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1. Gut 1990, 31:886-889.
31. Blanshard C, Gazzard BG: Incidence and cause of transient and persisting diarrhoea in relation to CD4 lymphocyte count in HIV-infected individuals. Eur J Gastroenterol Hepatol 1993, 5:823-828.
32. Macallan DC, Noble C, Baldwin C, Foskett M, McManus T, Griffin GE: Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 1993, 58:417-424.
33. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, Sawyer MB, McManus TJ, Griffin GE: Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995, 333:83-88 The precise mechanisms of HIV-associated weight loss are elusive. Fifty-one assessments of energy metabolism in 27 men with HIV infection revealed that reduced energy intake rather than increased energy expenditure was the prime determinant of weight loss in HIV-associated wasting.
34. Kapembwa MS, Fleming SC, Griffin GE, Caun K, Pinching AJ. Harris JR: Fat absorption and exocrine pancreatic function in human immunode-ficiency virus infection. Q J Med 1990, 74:49-56.
35. Ehrenpreis ED, Ganger DR, Kochvar GT, Patterson BK, Craig RM: D-xylose malabsorption: characteristic finding in patients with the AIDS wasting syndrome and chronic diarrhea. J Acquir Immune Defic Syndr 1992, 5:1047-1050.
36. Kapemba MS, Bridges C, Josef AEA, Fleming SC, Batman P, Griffin GE: Heal and jejunal absorptive function in patients with AIDS and enterococcidial infection. J Infect 1990, 21:43-53.
37. Budhraja M, Levendoglu H, Kocka F, Mangkornkanok M, Sherer R: Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome. Am J Gastroenterol 1987, 82:427-431.
38. Lambl BB, Federman M, Pleskow D, Wanke CA: Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea. AIDS 1996, 10:739-744.
39. Kapembwa MS, Batman PA, Fleming SC, Griffin GE: HIV enteropathy. Lancet 1989, 2:1521-1522.
40. Reeves-Darby VG, Mathias JR, Clench MH: Abnormal gastrointestinal motility in patients with human immunodeficiency virus 1 (HIV-1) [abstract]. Gastroenterology 1991, 100:A608.
41. Kotler DP, Gaetz HP, Lange M, Klein EB, Holt PR: Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984, 101:421-428.
42. McGowan I, Campbell A, Jewell DP: Intestinal mucosal abnormality associated with human immunodeficiency virus infection. Eur J Gastroenterol Hepatol 1994, 6:813-819.
43. Keating J, Bjarnason I, Somasundaram S, Macpherson A, Francis N, Price AB, Sharpstone D, Smithson J, Menzies IS, Gazzard BG: Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 1995, 37:623-629 Malabsorption and increased intestinal permeability are common in patients with AIDS. However, in contrast to celiac disease, small intestinal morphology was relatively preserved.
44. Obinna FC, Cook G, Beale T, Dave S, Cunningham D, Fleming SC, Claydon E, Harris JW, Kapembwa MS: Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men. AIDS 1995, 9:1009-1016.
45. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmedyian NS, Cone L, Brennan PJ, Weitzman SA: Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994, 121:393-399.
46. Engelson ES, Pi-Sunyer FX, Kotler DP: Effect of megestrol acetate therapy on body composition and circulating testosterone concentrations in patients with AIDS. AIDS 1995, 9:1107-1108.
47. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M: Anabolic effects of recombinant growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993, 77:956-962.
48. Dowling S, Kane D, Chua A, Keating S, Flood P, Keeling PWN, Mulcahy FM: An evaluation of percutaneous endoscopic gastrostomy feeding in AIDS, Int J STD AIDS 1996, 7:106-109.
49. Melchior JC, Chastang C, Gelas P, Carbonnel F, Zazzo JF, Boulier A, Cosnes J, Bouletreau P, Messing B: Efficacy of 2-month total parenteral nutrition in AIDS patients: a controlled randomized prospective trial. AIDS 1996, 10:379-384.
50. Sprague V, Becnel JJ, Hazard El: Taxonomy of phylum Microspora. Crit Rev Microbiol 1992, 18:285-395.
51. Kotler DP, Orenstein JM: Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation. Am J Gastroenterol 1994, 89:1998-2002.
52. Luna VA, Stewart BK, Bergeron DL, Clausen CR, Plorde JJ, Fritsche TR: Use of the fluorochrome calcofluor white in the screening of stool specimens for spores of microsporidia. Am J Clin Pathol 1995, 103:656-659.
53. DeGirolami PC, Ezratty CR, Desai G, McCullough A, Asmuth D, Wanke C, Federman M: Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber's modified trichrome and Uvitex 2B strains. J Clin Microbiol 1995, 33:805-810.
54. Franzen C, Muller A, Hegener P, Hartmann G, Salzberger B, Franzen B, Diehl V, Fatkenheuer G: Polymerase chain reaction for microsporidian DNA in gastrointestinal biopsy specimens of HIV-infected patients. AIDS 1996, 10:F23-F27. Polymerase chain reaction amplification of the small subunit rRNA gene in DNA extracted from intestinal tissue biopsies offers a new technique to diagnose microsporidial infection and to discriminate between infection with E. bienusi and E. (Septata) intestinalis species.
55. Eeftinck Schattenkerk JK, van Gool T, van Ketel RJ, Bartelsman JF, Kuiken CL, Terpstra WJ, Reiss P: Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 1991, 337:895-898.
56. Blanshard C, Ellis DS, Tovey DG, Dowell S, Gazzard BG: Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS 1992, 6:311-313.
57. Dieterich DT, Lew EA, Kotler DP, Poles MA, Orenstein JM: Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis 1994, 169:178-183.
58. Molina JM, Oksenhendler E, Beauvais B, Sarfati C, Jaccard A, Derouin F, Modai J: Disseminated microsporidiosis due to Septate intestinalis in patients with AIDS: clinical features and response to albendazole therapy. J Infect Dis 1995, 171:245-249.
59. Weber R, Sauer B, Spycher MA, Deplazes P, Keller R, Ammann R, Briner J, Luthy R: Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. Clin Infect Dis 1994, 19:342-345.
60. Franzen C, Muller A, Schwenk A, Salzberger B, Fatkenheuer G, Mahrle G, Diehl V, Schrappe M: Intestinal microsporidiosis with Septata intestinalis in a patient with AIDS: response to albendazole. J Infect 1995, 31:237-239.
61. Sharpstone D, Rowbottom A, Nelson M, Gazzard B: The treatment of microsporidial diarrhoea with thalidomide [letter]. AIDS 1995, 9:658-659.
62. Anwar-Bruni DM, Hogan SE, Schwartz DA, Wilcox CM, Bryan RT, Lennox JL: Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients. AIDS 1996, 10:619-623.
63. Beral V, Peterman TA, Berkelman RL, Jaffe HW: Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990, 335:123-128.
64. Chang Y, Cesarman E, Pessin MP, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
65. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995, 332:1181-1185.
66. Thomas JA, Brookes LA, McGowan I, Weller I, Crawford DH: HHV8 DNA in normal gastrointestinal mucosa from HIV seropositive people. Lancet 1996, 347:1337-1338.